Publication

Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme

Challapalli, A
; 
Watkins, S
; 
Cogill, G
; 
Stewart, G
; 
Ellis, S
; 
Sykes, A
; 
Nobes, J
; 
Yip, K
; 
Barthakur, U
; 
Board, R
... show 7 more
Abstract
No abstract available.
MIDER Authors
Watkins, Steven
Citations
Altmetric:
Date
2022-03-17
Type
Correspondence
Subject
Oncology. Pathology., Dermatology
Collections
UHB Oncology
Show all metadata
Citation
Challapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, Nobes J, Yip K, Barthakur U, Board R, Gadve A, O'Toole L, Kent C, Mackenzie J, Papa S, Fusi A, Fife K. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e590-e592. doi: 10.1111/jdv.18082. Epub 2022 Mar 24.
Journal / Source Title
Journal of the European Academy of Dermatology and Venereology
DOI
10.1111/jdv.18082
URI
http://hdl.handle.net/20.500.14200/2418
PMID
35298050
Publisher
Wiley
Publisher’s URL
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-3083
Publisher’s statement
Note / Copyright